- call +1-201-465-4211
- email sales@mrinsights.biz
Lentiviral are vectors that are derived from the virus known as human immunodeficiency virus and is used to transfer gene in the cells, such as mammalian cell and others. Lentiviruses are used for transfection in non-dividing and actively dividing cell. This acts as an advantage to another type of retrovirus. The lentiviruses fall in the category of a retrovirus. The lentiviral expression system is developed, which can influence the gene of interest. The commercially available lentiviral expression systems are available in combination with tag sequence, reporter gene, promoters and multicistronic vectors are also available for desired protein expression. These vectors are used for research and development purpose recombinant protein expression, protein characterization, in-vitro transcription, and other functional arrays.
Scope of the Report:
This report studies the Lentiviral Expression Systems market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Lentiviral Expression Systems market by product type and applications/end industries.
Based on the expression system components, global lentiviral expression system market is segmented lentiviral promoter, which is further sub-segmented as lentivirus promoter vectors, lentivirus promoterless vectors, lentiviral fusion tags lentivirus packaging systems and other accessories. Based on the application type, global lentiviral expression system market is segmented as recombinant protein expression, functional assays, protein characterization, In vitro transcription and other application for research and study purpose. On the basis of end user, the global lentiviral expression system market is segmented into biotechnological companies, pharmaceutical companies, contract research organizations, academic/ research institutes.
North America is estimated to lead the global lentiviral expression systems market due to increasing focus on protein expression and production, growing demand for simple and efficient protein production methods, government funding for research and development in developed countries and others. . Increasing applications in various areas such as protein structural analysis, protein expression & purification, functional genomics, determining protein-protein interactions are projected to boost growth of the lentiviral expression system during the forecast period. Europe market is also projected to experience high growth due to emphasis on up-scaling and industrial application in the near future. Asia Pacific market is anticipated to grow at the fastest growth rate during the forecast period, owing to factors such as focusing on healthcare expenditures, rise in research and development facilities and others.
The global Lentiviral Expression Systems market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Lentiviral Expression Systems.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Dharmacon
Thermo Fisher Scientific
Merck KGaA
Takara Bio
ABM Industries
Cell Biolabs
GeneCopoeia
System Biosciences
Fujifilm Diosynth Biotechnologies
ATUM
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Lentiviral Promoter
Lentiviral Fusion Tags
Lentivirus Packaging Systems
Other
Market Segment by Applications, can be divided into
Biotechnology Companies
Pharmaceutical Companies
Contract Research Organizations
Academic/Research Institutes
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Lentiviral Expression Systems Market Overview
1.1 Product Overview and Scope of Lentiviral Expression Systems
1.2 Classification of Lentiviral Expression Systems by Types
1.2.1 Global Lentiviral Expression Systems Revenue Comparison by Types (2017-2023)
1.2.2 Global Lentiviral Expression Systems Revenue Market Share by Types in 2017
1.2.3 Lentiviral Promoter
1.2.4 Lentiviral Fusion Tags
1.2.5 Lentivirus Packaging Systems
1.2.6 Other
1.3 Global Lentiviral Expression Systems Market by Application
1.3.1 Global Lentiviral Expression Systems Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Biotechnology Companies
1.3.3 Pharmaceutical Companies
1.3.4 Contract Research Organizations
1.3.5 Academic/Research Institutes
1.4 Global Lentiviral Expression Systems Market by Regions
1.4.1 Global Lentiviral Expression Systems Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Lentiviral Expression Systems Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Lentiviral Expression Systems Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Lentiviral Expression Systems Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Lentiviral Expression Systems Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Lentiviral Expression Systems Status and Prospect (2013-2023)
1.5 Global Market Size of Lentiviral Expression Systems (2013-2023)
2 Manufacturers Profiles
2.1 Dharmacon
2.1.1 Business Overview
2.1.2 Lentiviral Expression Systems Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Dharmacon Lentiviral Expression Systems Revenue, Gross Margin and Market Share (2016-2017)
2.2 Thermo Fisher Scientific
2.2.1 Business Overview
2.2.2 Lentiviral Expression Systems Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Thermo Fisher Scientific Lentiviral Expression Systems Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck KGaA
2.3.1 Business Overview
2.3.2 Lentiviral Expression Systems Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck KGaA Lentiviral Expression Systems Revenue, Gross Margin and Market Share (2016-2017)
2.4 Takara Bio
2.4.1 Business Overview
2.4.2 Lentiviral Expression Systems Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Takara Bio Lentiviral Expression Systems Revenue, Gross Margin and Market Share (2016-2017)
2.5 ABM Industries
2.5.1 Business Overview
2.5.2 Lentiviral Expression Systems Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 ABM Industries Lentiviral Expression Systems Revenue, Gross Margin and Market Share (2016-2017)
2.6 Cell Biolabs
2.6.1 Business Overview
2.6.2 Lentiviral Expression Systems Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Cell Biolabs Lentiviral Expression Systems Revenue, Gross Margin and Market Share (2016-2017)
2.7 GeneCopoeia
2.7.1 Business Overview
2.7.2 Lentiviral Expression Systems Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 GeneCopoeia Lentiviral Expression Systems Revenue, Gross Margin and Market Share (2016-2017)
2.8 System Biosciences
2.8.1 Business Overview
2.8.2 Lentiviral Expression Systems Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 System Biosciences Lentiviral Expression Systems Revenue, Gross Margin and Market Share (2016-2017)
2.9 Fujifilm Diosynth Biotechnologies
2.9.1 Business Overview
2.9.2 Lentiviral Expression Systems Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Fujifilm Diosynth Biotechnologies Lentiviral Expression Systems Revenue, Gross Margin and Market Share (2016-2017)
2.10 ATUM
2.10.1 Business Overview
2.10.2 Lentiviral Expression Systems Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 ATUM Lentiviral Expression Systems Revenue, Gross Margin and Market Share (2016-2017)
3 Global Lentiviral Expression Systems Market Competition, by Players
3.1 Global Lentiviral Expression Systems Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Lentiviral Expression Systems Players Market Share
3.2.2 Top 10 Lentiviral Expression Systems Players Market Share
3.3 Market Competition Trend
4 Global Lentiviral Expression Systems Market Size by Regions
4.1 Global Lentiviral Expression Systems Revenue and Market Share by Regions
4.2 North America Lentiviral Expression Systems Revenue and Growth Rate (2013-2018)
4.3 Europe Lentiviral Expression Systems Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Lentiviral Expression Systems Revenue and Growth Rate (2013-2018)
4.5 South America Lentiviral Expression Systems Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Lentiviral Expression Systems Revenue and Growth Rate (2013-2018)
5 North America Lentiviral Expression Systems Revenue by Countries
5.1 North America Lentiviral Expression Systems Revenue by Countries (2013-2018)
5.2 USA Lentiviral Expression Systems Revenue and Growth Rate (2013-2018)
5.3 Canada Lentiviral Expression Systems Revenue and Growth Rate (2013-2018)
5.4 Mexico Lentiviral Expression Systems Revenue and Growth Rate (2013-2018)
6 Europe Lentiviral Expression Systems Revenue by Countries
6.1 Europe Lentiviral Expression Systems Revenue by Countries (2013-2018)
6.2 Germany Lentiviral Expression Systems Revenue and Growth Rate (2013-2018)
6.3 UK Lentiviral Expression Systems Revenue and Growth Rate (2013-2018)
6.4 France Lentiviral Expression Systems Revenue and Growth Rate (2013-2018)
6.5 Russia Lentiviral Expression Systems Revenue and Growth Rate (2013-2018)
6.6 Italy Lentiviral Expression Systems Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Lentiviral Expression Systems Revenue by Countries
7.1 Asia-Pacific Lentiviral Expression Systems Revenue by Countries (2013-2018)
7.2 China Lentiviral Expression Systems Revenue and Growth Rate (2013-2018)
7.3 Japan Lentiviral Expression Systems Revenue and Growth Rate (2013-2018)
7.4 Korea Lentiviral Expression Systems Revenue and Growth Rate (2013-2018)
7.5 India Lentiviral Expression Systems Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Lentiviral Expression Systems Revenue and Growth Rate (2013-2018)
8 South America Lentiviral Expression Systems Revenue by Countries
8.1 South America Lentiviral Expression Systems Revenue by Countries (2013-2018)
8.2 Brazil Lentiviral Expression Systems Revenue and Growth Rate (2013-2018)
8.3 Argentina Lentiviral Expression Systems Revenue and Growth Rate (2013-2018)
8.4 Colombia Lentiviral Expression Systems Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Lentiviral Expression Systems by Countries
9.1 Middle East and Africa Lentiviral Expression Systems Revenue by Countries (2013-2018)
9.2 Saudi Arabia Lentiviral Expression Systems Revenue and Growth Rate (2013-2018)
9.3 UAE Lentiviral Expression Systems Revenue and Growth Rate (2013-2018)
9.4 Egypt Lentiviral Expression Systems Revenue and Growth Rate (2013-2018)
9.5 Nigeria Lentiviral Expression Systems Revenue and Growth Rate (2013-2018)
9.6 South Africa Lentiviral Expression Systems Revenue and Growth Rate (2013-2018)
10 Global Lentiviral Expression Systems Market Segment by Type
10.1 Global Lentiviral Expression Systems Revenue and Market Share by Type (2013-2018)
10.2 Global Lentiviral Expression Systems Market Forecast by Type (2018-2023)
10.3 Lentiviral Promoter Revenue Growth Rate (2013-2023)
10.4 Lentiviral Fusion Tags Revenue Growth Rate (2013-2023)
10.5 Lentivirus Packaging Systems Revenue Growth Rate (2013-2023)
10.6 Other Revenue Growth Rate (2013-2023)
11 Global Lentiviral Expression Systems Market Segment by Application
11.1 Global Lentiviral Expression Systems Revenue Market Share by Application (2013-2018)
11.2 Lentiviral Expression Systems Market Forecast by Application (2018-2023)
11.3 Biotechnology Companies Revenue Growth (2013-2018)
11.4 Pharmaceutical Companies Revenue Growth (2013-2018)
11.5 Contract Research Organizations Revenue Growth (2013-2018)
11.6 Academic/Research Institutes Revenue Growth (2013-2018)
12 Global Lentiviral Expression Systems Market Size Forecast (2018-2023)
12.1 Global Lentiviral Expression Systems Market Size Forecast (2018-2023)
12.2 Global Lentiviral Expression Systems Market Forecast by Regions (2018-2023)
12.3 North America Lentiviral Expression Systems Revenue Market Forecast (2018-2023)
12.4 Europe Lentiviral Expression Systems Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Lentiviral Expression Systems Revenue Market Forecast (2018-2023)
12.6 South America Lentiviral Expression Systems Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Lentiviral Expression Systems Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Lentiviral Expression Systems Picture
Table Product Specifications of Lentiviral Expression Systems
Table Global Lentiviral Expression Systems and Revenue (Million U
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
